Condition (MeSH)
White Coat Hypertension
ClinicalTrials.gov lists 15 trials for White Coat Hypertension or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
15 of the 15 trials are tagged with White Coat Hypertension itself; the rest are tagged with a narrower condition beneath it.
When did White Coat Hypertension trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 2 |
| 2024 | 1 |
| 2021 | 1 |
| 2019 | 1 |
| 2018 | 3 |
| 2016 | 1 |
| 2015 | 2 |
| 2010 | 1 |
| 2009 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are White Coat Hypertension trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 1 |
| Not applicable | 7 |
| Observational | 7 |
How many White Coat Hypertension trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Completed | 9 |
| Unknown status | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Interventions as named in the registry (4)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Antihypertensiva, mainly Metyldopa | 1 |
| Antihypertensive treatment will be stopped for 1 year unless hypertension recurrence | 1 |
| D. Midazolam | 1 |
| candsartan cilexetil | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover White Coat Hypertension? (44)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Resistant Hypertension in Dialysis: Epidemiology, Diagnosis, and Management. | Journal of the American Society of Nephrology : JASN | 2024 | Yes |
| Sex Differences in Ambulatory Blood Pressure Levels and Subtypes in a Large Italian Community Cohort. | Hypertension (Dallas, Tex. : 1979) | 2023 | Yes |
| Exploring the effect of virtual reality relaxation environment on white coat hypertension in blood pressure measurement. | Journal of biomedical informatics | 2021 | Yes |
| Feasibility of 24-h blood pressure telemonitoring in community pharmacies: the TEMPLAR project. | Journal of hypertension | 2021 | Yes |
| Randomized Controlled Trial Comparing Automated Office Blood Pressure Readings After Zero or Five Minutes of Rest. | Hypertension (Dallas, Tex. : 1979) | 2021 | Yes |
Showing 5 of 44 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.